Medicare drug coverage

Uptravi: 2027 Medicare Part D coverage

3,187 of 5,495 Part D plans (58%) list Uptravi on their 2027 formulary, the plan's list of covered drugs (down 2 points from 2026). 97% of those require prior authorization, step therapy, or a quantity limit. Plan counts include both Medicare Advantage plans with drug coverage (5,172 MA-PD) and stand-alone drug plans (323 PDP).

License: a US government work, in the public domain (Public Domain Mark 1.0).

Data only, not plan advice. Confirm on Medicare.gov Plan Finder or 1-800-MEDICARE.

2027 compared with 2026

Uptravi is number 51 by total Medicare Part D spending in 2024 ($909 million). Plans that list it most often put it on tier 5 (a tier is the cost level a plan puts a drug on; a lower tier usually costs less). Counts use 13 RxNorm products for this name.

Uptravi Part D coverage, 2026 and 2027
Measure20262027Change
Part D plans in the file5,5185,495-23
Plans that list it3,332 (60%)3,187 (58%)-2 points
Prior authorization (of plans that list it)3,232 (97%)3,083 (97%)no change
Step therapy (of plans that list it)0 (0%)0 (0%)no change
Quantity limit (of plans that list it)3,120 (94%)3,081 (97%)+3 points
Any of the three (of plans that list it)3,232 (97%)3,090 (97%)no change
Not listed or restricted (of all plans)5,418 (98%)5,398 (98%)no change

Source: CMS 2027 Part D formulary file (basic drugs and plan information), as of October 8, 2026. Publisher page

Source: CMS 2026 Part D formulary file (basic drugs and plan information), as of September 30, 2026. Publisher page

For pharmacies and agencies: check a whole drug list against 2027 formularies.

Upload your patient list or your book of clients and Rivvi checks each drug against the CMS 2027 formulary files, plan by plan, so you see tier changes and new limits before the next refill or open enrollment. Free to start. HIPAA BAA included.

For pharmaciesFor agencies

Formulary tier

Uptravi formulary tier, 2026 and 2027
Tier2026 plans2027 plans
Tier 191 (3%)55 (2%)
Tier 22 (0%)1 (0%)
Tier 420 (1%)23 (1%)
Tier 53,199 (96%)3,108 (98%)
Tier 620 (1%)0 (0%)

Source: CMS 2027 Part D formulary file (basic drugs and plan information), as of October 8, 2026. Publisher page

Source: CMS 2026 Part D formulary file (basic drugs and plan information), as of September 30, 2026. Publisher page

Plan by plan, 2026 to 2027

4,380 plan IDs are in both files. 63 of them (1%) added prior authorization, step therapy, or a quantity limit for Uptravi, and 280 stopped listing it.

Uptravi: plans in both 2026 and 2027
Plan by planPlans
Same plan ID in both years4,380
Listed it in 2026, not in 2027280 (6%)
Listed it in 2027, not in 202618 (0%)
Moved it to a higher tier24 (1%)
Added prior authorization0 (0%)
Added step therapy0 (0%)
Added a quantity limit63 (1%)
Added at least one of the three63 (1%)
Removed at least one of the three1 (0%)
Plan IDs new in 20271,115
2026 plan IDs not in the 2027 file1,138

Source: CMS 2027 Part D formulary file (basic drugs and plan information), as of October 8, 2026. Publisher page

Source: CMS 2026 Part D formulary file (basic drugs and plan information), as of September 30, 2026. Publisher page

States from most to least restrictive

Share of 2027 Part D plans offered in each state that leave Uptravi off the formulary or list it with prior authorization, step therapy, or a quantity limit. 41 states tie for the highest share, 100%; Maryland ranks last at 80%. States at the same share are ordered by the prior authorization or step therapy share; states equal on both shares share a rank, marked Tied.

States from most to least restrictive for Uptravi, 2027
RankState2027 plansNot listed or restrictedPrior auth or step therapyChange from 2026
Tied 1Illinois133100%68%no change
Tied 1Missouri171100%68%no change
Tied 3New York215100%67%no change
Tied 3Louisiana126100%67%no change
Tied 5Arkansas86100%65%no change
Tied 5Tennessee157100%65%no change
7Vermont14100%64%no change
Tied 8Kansas84100%63%no change
Tied 8Ohio173100%63%no change
Tied 8Montana27100%63%no change
Tied 8West Virginia70100%63%no change
12Alabama115100%62%no change
Tied 13Utah53100%60%no change
Tied 13Pennsylvania324100%60%no change
Tied 13New Hampshire25100%60%no change
Tied 16Arizona148100%59%no change
Tied 16Kentucky123100%59%no change
Tied 16Connecticut54100%59%no change
Tied 16Oklahoma81100%59%no change
Tied 16Nevada100100%59%no change
Tied 21Florida549100%58%no change
Tied 21Indiana140100%58%no change
23Maine52100%54%no change
Tied 24Delaware43100%53%no change
Tied 24South Carolina91100%53%no change
Tied 24North Carolina177100%53%no change
Tied 27Mississippi105100%51%no change
Tied 27Texas412100%51%no change
29Massachusetts92100%50%no change
Tied 30Nebraska51100%49%no change
Tied 30New Jersey74100%49%no change
32Iowa64100%47%no change
33Alaska9100%44%no change
34New Mexico68100%40%no change
35Wyoming13100%38%no change
Tied 36Rhode Island29100%34%no change
Tied 36Michigan183100%34%no change
38South Dakota30100%33%no change
39Idaho45100%31%no change
40Minnesota63100%29%no change
41North Dakota26100%23%no change
42Wisconsin9799%43%no change
43Washington11497%58%-1 point
44Oregon9296%61%no change
45Virginia14596%54%no change
46Georgia15195%50%no change
47Colorado10690%53%+3 points
48Hawaii5088%64%no change
49California39788%50%no change
50District of Columbia2186%38%-2 points
51Maryland4980%51%-4 points

Source: CMS CY2027 landscape file (states and parent organizations), as of September 30, 2026. Publisher page

Source: CMS 2027 Part D formulary file (basic drugs and plan information), as of October 8, 2026. Publisher page

By parent organization

164 parent organizations offer 2027 Part D plans. Humana Inc. has the most, 884, and 100% of them leave Uptravi off or restrict it.

Uptravi coverage by parent organization, 2027
Parent organization2027 plans ↑List itRestrict it (of listing)Not listed or restrictedChange from 2026Plans that added a restriction
CoxHealth3100%100%100%no change0
First Sacramento Capital Funding LLC30%none list it100%no change0
Imperial Health Plan of California3100%100%100%no change0
Liberty Healthcare Insurance30%none list it100%no change0
Marquis Companies I, Inc.30%none list it100%no change0
McLaren Health Care Corporation3100%100%100%no change0
MedCare Partners Holding, LLC3100%100%100%new in 20270
Mercy Care3100%100%100%no change0
New York City Health and Hospitals Corporation3100%100%100%no change0
Presbyterian Healthcare Services30%none list it100%no change0
SIHO Holding, Inc.3100%100%100%no change0
St. Luke's Health System, Inc.30%none list it100%new in 20270
VISITING NURSE ASSOCIATION OF CENTRAL NEW YORK3100%100%100%no change0
Village Care of New York, Inc.3100%100%100%no change0
Visiting Nurse Service of New York3100%100%100%no change0
Chapters CareNu Inc40%none list it100%no change0
Chinese Hospital Association4100%100%100%no change0
El Paso County Hospital District40%none list it100%no change0
Elderplan, Inc.4100%100%100%no change0
Horizon Mutual Holdings, Inc40%none list it100%no change0
LMC Family Holdings, LLC4100%100%100%no change0
Montage Health4100%100%100%no change0
St Francis Health System & St John Health System40%none list it100%no change0
Blue Cross & Blue Shield of Rhode Island50%none list it100%no change0
BlueCross BlueShield of Alabama50%none list it100%no change0

Source: CMS CY2027 landscape file (states and parent organizations), as of September 30, 2026. Publisher page

Source: CMS 2027 Part D formulary file (basic drugs and plan information), as of October 8, 2026. Publisher page

Near it by Part D spending

About this data

A plan here is one Part D plan as the CMS formulary files list it: contract, plan, and segment. That covers Medicare Advantage plans with drug coverage and stand-alone drug plans. A plan lists a drug when its formulary has a row for any RxNorm product of that name. When it has several, the row with the lowest tier is the one counted, and restricted means that row has prior authorization, step therapy, or a quantity limit.

A plan with no row for the drug counts as not listing it. That can be a product the file codes another way, so read a low count as a lookup result, not a coverage decision. A state counts every plan the CMS landscape file offers there. Parent organizations are named as CMS names them. The drug list is the top 200 by total Part D spending.

Source: CMS 2027 Part D formulary file (basic drugs and plan information), as of October 8, 2026. Publisher page

Source: CMS CY2027 landscape file (states and parent organizations), as of September 30, 2026. Publisher page

Source: CMS Medicare Part D Spending by Drug, 2024 data, as of June 25, 2026. Publisher page

Try it on your own data today.

Free to start. Most teams are using it the same day.

Get started for freeSee pricing